Hospitals & Providers

The results of Geneia’s year-long study – a savings of $8,375 per patient and a slowing of disease progression – demonstrate that remote patient monitoring is a wise investment for payers.

A new Express Scripts report highlights risk reporting gaps and offers advice for plans looking to close those gaps to ensure accurate risk payments

Study examines the effectiveness of the Walgreens Connected Care CF program compared to a matched sample of control patients.

ACA repeal/replace was a Congressional Republican cornerstone, so there will be lots of pressure to move quickly. But that may be easier said than done.

A new report highlights the highest uninsured rates by state. Is your state among the top 10?

Failure to report accurate data can result in significant penalties for Medicaid managed care plans.

PwC report finds most primary care teams not designed to optimize care. Here’s how to mobilize non-physicians to create a care dream team.

Alcohol and drug dependency treatment goals can tied to an insurer’s pay-for-performance incentive program. Here’s how.

Lay the groundwork for bundled payment; here are three areas in which technology can play a role.

How to really understand patient experience and improve outcomes. Here are five tips to help you create a culture of excellence.

Here are some of the latest precision medicine approaches being used by managed care organizations, health systems and academic medical centers across the U.S.

As the industry moves toward value-based care, medical education must keep pace.

The Leapfrog Group recently released its latest hospital safety grades, and they indicate some interesting trends on a state-by-state basis.

The Cancer MoonShot 2020 program brings together stakeholders from pharma, community and academic oncology, as well as government and scientific communities in an effort to accelerate the potential of combination immunotherapy as the next-generation standard of care in cancer patients.

Drugs will be provided to health plan members on clinical trials free of charge.

As part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder.

A recent survey suggests suggest a lack of access to appropriate commercial payer arrangements is causing health systems to explore alternatives.

Cancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.

A new cancer database, the Genomic Data Commons, aims to make research more accessible

A new Commonwealth Fund study explores cost-sharing reduction plans and marketplace coverage.

Payers have a direct interest in preserving independent physician practices andhelping all physicians regain the Joy of Medicine.

The advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are.

It’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation.

MCOs are going to have to step up their efforts to impact the growing opioid epidemic in this country.

It’s time to step back and assess how the election could impact the managed care industry.

While healthcare has flown under the radar for much of this election season, it’s a topic that was not ignored at the Academy of Managed Care Pharmacy (AMCP) Nexus in National Harbor, Maryland.

Approvals of specialty pharmaceuticals have far outpaced traditional drugs, and that trend will continue. But that’s not the only specialty medication trend that healthcare executives should have on their radar.

Understanding both candidates proposals can help executives make informed decisions.

Here are the top 10 states that deliver the best healthcare services, according to personal-finance website WalletHub.

As the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.